UPDATE 1-FDA panel to focus on safety of Novartis gene therapy … – Business Insider
|
UPDATE 1-FDA panel to focus on safety of Novartis gene therapy …
Business Insider July 10 (Reuters) – The U.S. Food and Drug Administration will ask a panel of advisors to focus on the safety of Novartis AG's experimental gene therapy drug … Novartis' CAR-T Therapy for Pediatric Leukemia to Face FDA Advisory Panel |
